Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank33
3Y CAGR-44.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-44.5%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.31M | -53.6% |
| 2024 | $4.97M | +13.1% |
| 2023 | $4.40M | -67.5% |
| 2022 | $13.51M | +118.1% |
| 2021 | $6.20M | +156.4% |
| 2020 | $-10.99M | -3866.1% |
| 2019 | $-277000.00 | - |